Discontinued — last reported Q4 '25

Investing

Acquisitions

Boston Scientific Acquisitions increased by 487.6% to $523.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 118.8%, from $239.00M to $523.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -8.4% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$1.31B$244.00M$1.47B$0.00$71.00M$0.00$375.00M$643.00M$0.00$793.00M$47.00M$48.00M$1.13B$3.42B$239.00M$1.01B$256.00M$89.00M$523.00M
QoQ Change-81.3%+502.9%-100.0%-100.0%+71.5%-100.0%-94.1%+2.1%>999%+203.3%-93.0%+322.2%-74.6%-65.2%+487.6%
YoY Change-94.6%-100.0%-74.5%-100.0%-87.5%-92.5%+331.0%+408.5%>999%-77.3%-97.4%+118.8%
Range$0.00$3.42B
Avg YoY Growth+178.1%
Median YoY Growth-82.4%

Frequently Asked Questions

What is Boston Scientific's acquisitions?
Boston Scientific (BSX) reported acquisitions of $523.00M in Q1 2026.
How has Boston Scientific's acquisitions changed year-over-year?
Boston Scientific's acquisitions increased by 118.8% year-over-year, from $239.00M to $523.00M.
What is the long-term trend for Boston Scientific's acquisitions?
Over 4 years (2021 to 2025), Boston Scientific's acquisitions has grown at a -8.4% compound annual growth rate (CAGR), from $2.26B to $1.59B.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.